Next Article in Journal
Distal Fibula Reconstruction in Primary Malignant Tumours
Previous Article in Journal
New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas
Article

Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer

1
Department of Radiology and Nuclear Medicine, Prof. Kornel Gibiński Independent Public Central Clinical Hospital, Medical University of Silesia, Medyków 18, 40-514 Katowice, Poland
2
Students’ Scientific Society, Department of Radiology and Nuclear Medicine, Medical University of Silesia, Medyków 18, 40-514 Katowice, Poland
3
Department of Oncological Surgery, Prof. Kornel Gibiński Independent Public Central Clinical Hospital, Medical University of Silesia, Medyków 18, 40-514 Katowice, Poland
4
Department of Oncology and Radiotherapy, Prof. Kornel Gibiński Independent Public Central Clinical Hospital, Medical University of Silesia, Medyków 18, 40-514 Katowice, Poland
5
Department of Biochemistry and Medical Genetics, School of Health Sciences in Katowice, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland
6
1st Department of Orthopaedic and Trauma Surgery, District Hospital of Orthopaedics and Trauma Surgery, Bytomska 62, 41-940 Piekary Śląskie, Poland
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2021, 28(5), 3448-3462; https://doi.org/10.3390/curroncol28050298
Received: 9 August 2021 / Revised: 1 September 2021 / Accepted: 2 September 2021 / Published: 6 September 2021
(This article belongs to the Special Issue Breast Cancer Imaging and Therapy)
Background: Evaluating the tumor response to neoadjuvant chemotherapy is key to planning further therapy of breast cancer. Our study aimed to evaluate the effectiveness of low-energy and subtraction contrast-enhanced spectral mammography (CESM) images in the detection of complete response (CR) for neoadjuvant chemotherapy (NAC) in breast cancer. Methods: A total of 63 female patients were qualified for our retrospective analysis. Low-energy and subtraction CESM images just before the beginning of NAC and as a follow-up examination 2 weeks before the end of chemotherapy were compared with one another and assessed for compliance with the postoperative histopathological examination (HP). The response to preoperative chemotherapy was evaluated based on the RECIST 1.1 criteria (Response Evaluation Criteria in Solid Tumors). Results: Low-energy images tend to overestimate residual lesions (6.28 mm) and subtraction images tend to underestimate them (2.75 mm). The sensitivity of low-energy images in forecasting CR amounted to 33.33%, while the specificity was 92.86%. In the case of subtraction CESM, the sensitivity amounted to 85.71% and the specificity to 71.42%. Conclusions: CESM is characterized by high sensitivity in the assessment of CR after NAC. The use of only morphological assessment is insufficient. CESM correlates well with the size of residual lesions on histopathological examination but tends to underestimate the dimensions. View Full-Text
Keywords: contrast-enhanced spectral mammography; breast cancer; neoadjuvant chemotherapy; complete response; response evaluation criteria in solid tumors contrast-enhanced spectral mammography; breast cancer; neoadjuvant chemotherapy; complete response; response evaluation criteria in solid tumors
Show Figures

Figure 1

MDPI and ACS Style

Steinhof-Radwańska, K.; Grażyńska, A.; Lorek, A.; Gisterek, I.; Barczyk-Gutowska, A.; Bobola, A.; Okas, K.; Lelek, Z.; Morawska, I.; Potoczny, J.; Niemiec, P.; Szyluk, K. Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer. Curr. Oncol. 2021, 28, 3448-3462. https://doi.org/10.3390/curroncol28050298

AMA Style

Steinhof-Radwańska K, Grażyńska A, Lorek A, Gisterek I, Barczyk-Gutowska A, Bobola A, Okas K, Lelek Z, Morawska I, Potoczny J, Niemiec P, Szyluk K. Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer. Current Oncology. 2021; 28(5):3448-3462. https://doi.org/10.3390/curroncol28050298

Chicago/Turabian Style

Steinhof-Radwańska, Katarzyna, Anna Grażyńska, Andrzej Lorek, Iwona Gisterek, Anna Barczyk-Gutowska, Agnieszka Bobola, Karolina Okas, Zuzanna Lelek, Irmina Morawska, Jakub Potoczny, Paweł Niemiec, and Karol Szyluk. 2021. "Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer" Current Oncology 28, no. 5: 3448-3462. https://doi.org/10.3390/curroncol28050298

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop